- Home
- / TME Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
TME Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€0.1
2024-10-29
Market Capitalization
€6.1 M
2024-10-29
CreditSafe Score
?
Score changed on Jul 19, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Gross profit | 378.0K | 279.0K | 147.0K | 82.0K | 34.0K | 17.0K | 19.0K |
| Operating expense total | 4.7M | 4.2M | 5.8M | 13.5M | 11.9M | 5.5M | 5.2M |
| Depreciation and amortization | 23.0K | 47.0K | 62.0K | 67.0K | 92.0K | 144.0K | 84.0K |
| EBITDA | (4.3M) | (3.9M) | (5.7M) | (13.4M) | (11.9M) | (5.5M) | (5.2M) |
| EBIT | (4.3M) | (3.9M) | (5.8M) | (13.5M) | (12.0M) | (5.6M) | (5.3M) |
| Interest income | 388.0K | ||||||
| Interest expense | 6.8M | 3.0K | 5.1M | 1.5M | 3.4M | 1.5M | 503.0K |
| Pre tax profit | (10.7M) | (860.0K) | (10.4M) | (14.5M) | (15.1M) | (6.7M) | (5.7M) |
| Income tax expense | 1.0K | 1.0K | 1.0K | 7.0K | 2.0K | ||
| Net Income | (10.7M) | (861.0K) | (10.4M) | (14.5M) | (15.1M) | (6.7M) | (5.7M) |